LUNG Q4 2025 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$23M-4.9% YoY

Gross Profit

$18M77.6% margin

Operating Income

-$10M-43.8% margin

Net Income

-$10M-46.1% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+5.1%

Balance Sheet

Total Assets

$129M

Total Liabilities

$75M

Stockholders' Equity

$54M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$24M	-4.9%
Gross Profit	$18M	$18M	-0.3%
Operating Income	-$10M	-$13M	+26.2%
Net Income	-$10M	-$13M	+20.9%